摘要
目的探讨肝癌切除联合脾动脉结扎治疗肝癌并门静脉高压症的外科策略和疗效。方法回顾性分析2007年9月至2011年12月我院收治的肝癌合并门静脉高压症患者31例的临床资料和手术疗效。结果患者术前血小板计数平均为(59.50±22.43)×109/L,术后第2周血小板计数为(136.01±70.41)×109/L(P<0.05)。术前白细胞计数平均为(3.32±1.25)×109/L,术后第2周白细胞计数为(9.63±3.36)×109/L(P<0.05)。术前、术后红细胞计数以及脾动脉结扎前后门静脉压力相比较无统计学意义。结论选择性使用肝癌切除联合脾动脉结扎治疗肝癌并门静脉高压症可以缓解脾亢情况,有益于康复。
Objective To investigate the surgicalstrategyand curative effect of hepatic resection combined with splenic artery ligation in the treatment of hepatocellular carcinoma with portal hypertension.Methods Clinical data and operative effects in 31 patients subjected to hepatocellular carcinoma with portal hypertension from Sep.2007 to Dec.2011 were retrospectively analyzed.Results The average preoperative platelet count was（59.50 ± 22.43） ×109/L,platelet count for the second week after the operation was（136.01 ± 70.41）× 109/L（P 0.05）.An average of preoperative white blood count was（3.32 ± 1.25）× 109/L,white blood count was（9.63 ± 3.36） ×109/L for the second week after the operation（P 0.05）.Preoperative and postoperative red blood cell count had no statistically difference.So was portal vein pressure.Conclusion Hepatocellular carcinoma resection with splenic artery ligation is selectively used to treat hepatocellular carcinoma and portal hypertension,which can alleviate hypersplenism,and is useful for rehabilitation.
出处
《肝胆胰外科杂志》
CAS
2012年第5期356-358,共3页
Journal of Hepatopancreatobiliary Surgery
基金
常州市卫生局重大课题(ZD200704)
关键词
癌
肝细胞
高血压
门静脉
肝切除术
脾动脉
carcinoma
hepatocellular
hypertension
portal
hepatectomy
splenic artery
